molecular
method
becom
wide
use
detect
respiratori
pathogen
part
superior
sensit
rel
rapid
turnaround
time
abil
identifi
pathogen
slow
grow
difficult
cultur
recent
novel
influenza
pandem
serv
underscor
quickli
new
molecular
test
becom
avail
clinic
use
year
pcr
domin
amplif
method
recent
modif
technolog
emerg
allow
rapid
detect
multipl
pathogen
singl
test
review
focu
emerg
multiplex
molecular
technolog
clinic
util
detect
respiratori
pathogen
recent
influenza
pandem
heighten
awar
need
improv
diagnost
test
respiratori
pathogen
overlap
clinic
present
variou
respiratori
infect
possibl
reliabl
predict
pathogen
base
clinic
sign
symptom
moreov
rapid
diagnost
test
shown
reduc
length
hospit
stay
cost
test
viral
respiratori
tract
infect
discuss
emerg
multiplex
technolog
detect
quantifi
multipl
respiratori
pathogen
singl
test
exhaust
discuss
emerg
technolog
rather
overview
technolog
appli
respiratori
pathogen
tabl
note
none
test
describ
herein
clear
us
food
drug
administr
current
avail
research
use
brief
overview
technolog
present
along
publish
data
respiratori
viru
test
test
view
context
clinic
util
exampl
method
applic
nearpati
test
suit
test
clinic
laboratori
turnaround
time
result
affect
util
outpati
andor
inpati
diagnost
test
test
identifi
need
pathogen
identifi
less
pathogen
would
need
certain
clinic
set
final
result
alter
clinic
manag
lead
betterdirect
reduc
use
antivir
therapi
antibiot
respplex
technolog
qiaplex
technolog
qiagen
involv
nucleic
acid
purif
multiplex
amplif
polymeras
chain
reaction
pcr
follow
detect
use
liquidphas
beadbas
array
technolog
luminex
xmap
technolog
allow
high
degre
multiplex
detect
pathogen
singl
test
respplex
test
design
detect
bacteri
respiratori
pathogen
wherea
respplex
ii
test
detect
respiratori
virus
pathogen
multiplex
pcr
nest
genespecif
primer
design
includ
reaction
target
specif
primer
ad
low
concentr
use
enrich
target
first
cycl
pcr
inner
genespecif
primer
tag
sequenc
recogn
univers
set
primer
call
superprim
superprim
ad
higher
concentr
genespecif
primer
allow
exponenti
amplif
target
present
sampl
revers
superprim
label
biotin
ad
higher
concentr
forward
superprim
asymmetr
pcr
yield
revers
strand
detect
elimin
need
denatur
pcr
product
hybrid
probe
label
pcr
product
detect
use
captur
probe
specif
target
probe
coval
coupl
colorcod
bead
specif
target
correspond
uniqu
bead
color
biotinlabel
amplifi
product
detect
addit
streptavidinphycoerythrin
detect
occur
luminex
instrument
uniqu
color
bead
recogn
laser
presenc
absenc
phycoerythrinlabel
product
determin
whether
genespecif
target
present
sampl
uniqu
design
resplex
ii
system
allow
sensit
specif
reproduc
amplif
multipl
target
respplex
system
use
identifi
viral
bacteri
pathogen
patient
symptom
acut
respiratori
infect
test
use
one
studi
design
detect
pathogen
includ
common
viral
bacteri
pathogen
respiratori
sampl
test
pathogen
detect
includ
pathogen
virus
also
detect
direct
immunofluoresc
test
direct
fluoresc
antibodi
dfa
influenza
b
parainfluenza
respiratori
syncyti
viru
rsv
respplex
test
sensit
compar
dfa
adenoviru
resplex
test
sensit
compar
dfa
led
reconfigur
adenoviru
compon
test
anoth
studi
show
similar
result
sensit
respplex
ii
test
vari
compar
cultur
monoplex
realtim
pcr
assay
high
specif
although
sensit
pathogen
need
improv
overal
respplex
test
potenti
diagnost
tool
abil
detect
multipl
pathogen
singl
test
import
diagnost
advanc
provid
approach
studi
outcom
clinic
signific
coinfect
respplex
system
also
use
detect
influenza
viru
assay
design
target
gene
influenza
viru
well
ns
gene
influenza
influenza
b
virus
test
allow
detect
genotyp
influenza
b
virus
total
clinic
sampl
test
includ
sampl
human
infect
result
compar
viral
cultur
convent
realtim
reversetranscript
rt
pcr
respplex
test
clinic
sensit
specif
provid
rapid
method
identifi
subtyp
influenza
virus
respplex
test
detect
bacteri
pathogen
streptococcu
pneumonia
neisseria
meningitidi
haemophilu
influenza
legionella
pneumophila
mycoplasma
pneumonia
chlamydophila
pneumonia
use
test
formalinfix
paraffinembed
tissu
sampl
fatal
case
pneumonia
meningitismeningococcemia
confirm
immunohistochemistri
organismspecif
realtim
pcr
overal
respplex
test
identifi
case
singl
pathogen
multipl
pathogen
multiplex
test
valu
respiratori
specimen
formalinfix
paraffinembed
tissu
broad
differenti
limit
volum
specimen
advantag
resplex
ii
test
identifi
larg
number
pathogen
singl
test
howev
complex
test
multipl
step
requir
batch
specimen
turnaround
time
result
h
practic
nearpati
test
test
need
perform
clinic
laboratori
one
signific
limit
technolog
need
postamplif
manipul
sampl
greatli
increas
risk
carryov
contamin
could
lead
falseposit
result
infin
system
autogenom
coupl
multiplex
pcr
autom
microarray
hybrid
use
infin
analyz
nucleic
acid
extract
multiplex
convent
rtpcr
reaction
perform
primer
specif
respiratori
virus
amplif
amplicon
purifi
enzymat
step
remov
unincorpor
nucleotid
primer
subject
proprietari
primer
extens
step
within
infin
analyz
step
attach
specif
tag
amplicon
also
incorpor
fluorescentlabel
nucleotid
tag
label
amplicon
hybrid
antitag
immobil
microarray
allow
specif
identif
target
three
replic
antitag
microarray
provid
redund
primer
extens
tag
hybrid
scan
data
analysi
step
autom
perform
within
infin
analyz
recent
studi
raymond
et
al
compar
microarray
test
singletarget
quantit
realtim
pcr
assay
respiratori
virus
commonli
infect
children
nasopharyng
aspir
collect
children
year
age
hospit
acut
respiratori
tract
infect
overal
specimen
posit
viru
realtim
microarray
test
neg
virus
method
sampl
posit
realtim
test
virus
detect
microarray
test
common
virus
detect
rsv
influenza
coronavirus
rhinovirus
enterovirus
multipl
virus
found
specimen
result
compar
method
specimen
concord
sensit
microarray
test
virus
except
adenovirus
coronaviru
overal
singl
realtim
pcr
test
sensit
microarray
test
although
latter
requir
fewer
manual
step
specimen
h
less
handson
time
requir
throughput
higher
perform
individu
realtim
test
microarray
test
requir
sever
step
load
infin
analyz
design
batch
specimen
nucleic
acid
extract
rtpcr
enzym
digest
step
take
h
infin
analyz
load
first
result
avail
h
subsequ
result
requir
addit
min
base
complex
batch
time
requir
result
technolog
design
clinic
laboratori
nearpati
test
jaguar
system
handi
lab
recent
acquir
bd
diagnosticsgeneohm
coupl
autom
nucleic
acid
extract
method
realtim
pcr
technolog
detect
multipl
respiratori
pathogen
clinic
specimen
pipet
specimen
tube
reagent
dispos
nucleic
acid
extract
amplif
reaction
load
onto
instrument
nucleic
acid
extract
perform
individu
reagent
cartridg
load
jaguar
instrument
along
amplif
cartridg
remaind
test
complet
autom
proprietari
extract
method
allow
rapid
effici
purif
concentr
nucleic
acid
rel
larg
specimen
volum
ml
elut
volum
use
resuspend
amplif
reagent
amplif
step
perform
cartridg
cm
mm
thick
cartridg
accommod
reaction
reaction
volum
small
volum
allow
rapid
cycl
time
henc
entir
test
complet
min
system
use
realtim
pcr
multiplex
capabl
limit
target
howev
jaguar
system
sever
advantag
autom
simpl
use
essenti
requir
singl
pipett
step
use
realtim
pcr
postamplif
manipul
specimen
elimin
risk
carryov
contamin
eas
use
rapid
time
result
would
allow
system
place
rapidrespons
laboratori
emerg
depart
provid
nearpati
test
result
avail
quickli
enough
affect
clinic
manag
multiplex
assay
detect
influenza
influenza
b
rsv
nasopharyng
specimen
develop
jaguar
system
sensit
detect
influenza
influenza
b
rsv
respect
compar
tissu
cultur
result
overal
specif
period
clinic
sampl
test
posit
influenza
jaguar
assay
demonstr
posit
agreement
compar
laboratorydevelop
molecular
test
falseposit
find
note
neg
agreement
specimen
subtyp
found
detect
jaguar
test
although
assay
current
design
distinguish
influenza
subtyp
jaguar
system
requir
min
technic
h
test
specimen
filmarray
system
idaho
technolog
integr
nucleic
acid
extract
nest
pcr
detect
data
analysi
singleus
pouch
system
autom
enabl
detect
numer
viral
bacteri
respiratori
pathogen
singl
test
need
reagent
assay
enclos
singleus
pouch
addit
water
hydrat
lyophil
reagent
respiratori
specimen
pouch
load
filmarray
instrument
rest
test
complet
autom
extract
purif
nucleic
acid
nest
pcr
reaction
perform
within
pouch
firststep
pcr
multiplex
reaction
contain
primer
viral
bacteri
target
amplicon
first
pcr
dilut
second
round
pcr
reaction
perform
multiwel
array
well
contain
singl
primer
set
target
specif
pathogen
redund
built
array
target
amplifi
separ
well
use
amplif
melt
curv
analysi
filmarray
softwar
gener
result
target
system
robust
detect
low
concentr
pathogen
presenc
high
concentr
second
pathogen
result
avail
h
although
nest
pcr
use
system
close
risk
carryov
contamin
preliminari
studi
show
filmarray
system
detect
viral
pathogen
coinfect
dfa
test
respiratori
panel
develop
detect
adenovirus
bocavirus
conornavirus
influenza
b
influenza
subtyp
novel
metapneumonviru
parainfluenza
virus
rsv
rhinovirus
well
bordetella
pertussi
c
pneumonia
pneumonia
abil
detect
multipl
pathogen
within
h
simpl
setup
fulli
autom
system
rais
possibl
nearpati
test
filmarray
technolog
emerg
depart
outpati
clinic
current
instrument
limit
singl
test
per
run
multipl
instrument
may
need
depend
requir
throughput
scalabl
target
analysi
routin
star
technolog
primeradx
integr
convent
pcr
capillari
electrophoresi
provid
abil
detect
larg
number
pathogen
singl
reaction
also
uniqu
featur
provid
quantit
data
star
similar
principl
realtim
pcr
use
amplicon
size
instead
fluoresc
probe
identifi
target
nucleic
acid
extract
multiplex
pcr
reaction
set
uniqu
primer
specif
target
thermal
cycler
amplif
reaction
capillari
electrophoresi
devic
contain
iceplex
instrument
amplif
reaction
small
sampl
nanolit
master
mix
subject
capillari
electrophoresi
sequenti
sampl
everi
cycl
start
cycl
size
separ
signal
amplicon
increas
accumul
amplicon
plot
time
gener
amplif
curv
cycl
threshold
determin
target
differ
target
identifi
base
uniqu
size
amplicon
quantif
target
accomplish
ad
standard
master
mix
differ
concentr
uniqu
amplicon
size
standard
curv
gener
plot
cycl
threshold
valu
standard
known
concentr
curv
use
determin
concentr
target
amplif
capillari
electrophoresi
data
analysi
step
autom
iceplex
instrument
star
technolog
demonstr
larg
number
pathogen
singl
reaction
abil
quantifi
pathogen
may
prove
import
distinguish
colon
invas
diseas
pathogen
pneumonia
assay
requir
h
complet
test
perform
clinic
laboratori
sampl
batch
technolog
therefor
design
nearpati
test
instrument
close
system
minim
risk
carryov
contamin
current
test
quantif
cytomegaloviru
epsteinbarr
viru
bk
viru
human
herpesvirus
transplant
recipi
develop
evalu
test
respiratori
pathogen
also
plan
plexid
abbott
molecular
uniqu
system
combin
pcr
electrospray
ioniz
mass
spectrometri
esim
detect
broad
array
pathogen
includ
bacteria
virus
fungi
parasit
nucleic
acid
extract
purifi
clinic
specimen
multipl
pcr
reaction
perform
microtit
plate
use
primer
target
highli
conserv
region
microbi
genom
flank
variabl
region
type
primer
also
use
sequencebas
pathogen
identif
plate
load
plexid
analyz
autom
desalt
step
esim
determin
base
composit
data
analysi
amplifi
mixtur
inject
electrospray
ioniz
timeofflight
mass
spectromet
mass
amplicon
measur
mass
amplicon
possibl
determin
nucleotid
base
composit
ie
number
g
c
nucleotid
dna
molecul
requir
base
composit
forward
revers
strand
complementari
number
possibl
reduc
singl
unambigu
solut
organ
sampl
determin
compar
base
composit
observ
amplicon
databas
compris
known
sequenc
data
wide
array
pathogen
compar
cultur
nucleic
acid
probe
assay
limit
detect
microb
grow
target
assay
primer
sequenc
broadbas
approach
enabl
identif
known
emerg
unanticip
pathogen
plexid
system
use
identifi
viral
respiratori
pathogen
clinic
specimen
result
compar
expand
refer
standard
includ
combin
antigen
detect
cultur
pcr
method
plexid
system
perform
well
sensit
detect
influenza
b
rsv
sensit
detect
adenovirus
parainfluenza
virus
coronavirus
although
number
specimen
pathogen
low
pcresi
technolog
use
examin
sampl
obtain
militari
recruit
outbreak
respiratori
diseas
identifi
varieti
bacteri
pathogen
includ
h
influenza
n
meningitidi
streptococcu
pyogen
uniqu
technolog
detect
wide
array
pathogen
clinic
sampl
well
suit
pathogen
discoveri
evalu
emerg
pathogen
exampl
plexid
system
abl
determin
mix
lineag
swine
avian
human
novel
influenza
viru
pcresi
technolog
also
abl
identifi
distinguish
divers
collect
coronaviru
speci
includ
acut
respiratori
syndromeassoci
coronaviru
test
complet
h
system
design
use
clinic
laboratori
adapt
highthroughput
test
although
high
cost
instrument
date
limit
use
research
studi
wide
array
emerg
technolog
detect
quantif
respiratori
pathogen
directli
clinic
specimen
technolog
potenti
highthroughput
test
other
allow
rapid
nearpati
test
studi
need
fulli
elucid
perform
characterist
determin
ideal
clinic
applic
goal
identifi
test
improv
diagnost
test
respiratori
pathogen
affect
patient
manag
decis
lead
improv
patient
outcom
appropri
use
antivir
antibiot
andor
costeffect
deliveri
care
